The role of miRNA-155 in the immunopathogenesis of obliterative airway disease in mice induced by circulating exosomes from human lung transplant recipients with chronic lung allograft dysfunction

被引:14
作者
Bansal, Sandhya [1 ]
Itabashi, Yoshihiro [1 ]
Perincheri, Sudhir [2 ]
Poulson, Christin [1 ]
Bharat, Ankit [3 ]
Smith, Michael A. [1 ]
Bremner, Ross M. [1 ]
Mohanakumar, T. [1 ]
机构
[1] St Josephs Hosp, Norton Thorac Inst, 124 West Thomas Rd,Suite 105, Phoenix, AZ 85013 USA
[2] Yale Sch Med, New Haven, CT USA
[3] Northwestern Univ, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
miRNA; 155; Bronchiolitis obliterans syndrome; Obliterans airway disease; Immunization; Exosomes; IMMUNE; MICRORNA; SOCS; BIOGENESIS; ANTIBODIES;
D O I
10.1016/j.cellimm.2020.104172
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Human lung transplant recipients undergoing rejection induce circulatory exosomes with lung self-antigens (SAgs), K-alpha 1 Tubulin and Collagen V, and immunization of C57BL/6 mice with exosomes induced ob-literative airway disease (HEI-OAD). We analyzed whether exosomes with SAgs induced immunity in microRNA-155 knockout mice (miR-155KO), as microRNA-155 is an immune regulator. C57BL/6 and miR-155KO were immunized with exosomes from stable or chronic rejection (bronchiolitis obliterans syndrome (BOS) and on day 30, induction of exosomes, antibodies (Abs) to SAgs and cellular immunity were determined. C57BL/6 im-munized with exosomes from BOS developed OAD. These immunized animals also developed Abs to SAgs and increased frequency of SAg-specific IFN gamma and IL17-producing cells. In contrast, Abs to SAgs did not develop in miR-155KO and there was reduction in frequency of cells producing IL10. Upregulation of suppressor of cytokine signaling for lung inflammation was also noted resulting in abrogation of induction of exosomes with SAgs OAD.
引用
收藏
页数:8
相关论文
共 24 条
[1]   Suppressors of cytokine signalling (SOCS) in the immune system [J].
Alexander, WS .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :410-416
[2]   MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis [J].
Alivernini, Stefano ;
Gremese, Elisa ;
McSharry, Charles ;
Tolusso, Barbara ;
Ferraccioli, Gianfranco ;
McInnes, Iain B. ;
Kurowska-Stolarska, Mariola .
FRONTIERS IN IMMUNOLOGY, 2018, 8
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles [J].
Colombo, Marina ;
Raposo, Graca ;
Thery, Clotilde .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30, 2014, 30 :255-289
[5]   Principles and effects of microRNA-mediated post-transcriptional gene regulation [J].
Engels, B. M. ;
Hutvagner, G. .
ONCOGENE, 2006, 25 (46) :6163-6169
[6]   Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity [J].
Ferguson, Scott W. ;
Nguyen, Juliane .
JOURNAL OF CONTROLLED RELEASE, 2016, 228 :179-190
[7]   Antibodies to MHC Class I Induce Autoimmunity: Role in the Pathogenesis of Chronic Rejection [J].
Fukami, Naohiko ;
Ramachandran, Sabarinathan ;
Saini, Deepti ;
Walter, Michael ;
Chapman, William ;
Patterson, G. Alexander ;
Mohanakumar, Thalachallour .
JOURNAL OF IMMUNOLOGY, 2009, 182 (01) :309-318
[8]   miRBase: microRNA sequences, targets and gene nomenclature [J].
Griffiths-Jones, Sam ;
Grocock, Russell J. ;
van Dongen, Stijn ;
Bateman, Alex ;
Enright, Anton J. .
NUCLEIC ACIDS RESEARCH, 2006, 34 :D140-D144
[9]   Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection [J].
Gunasekaran, M. ;
Xu, Z. ;
Nayak, D. K. ;
Sharma, M. ;
Hachem, R. ;
Walia, R. ;
Bremner, R. M. ;
Smith, M. A. ;
Mohanakumar, T. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (02) :474-484
[10]   Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection [J].
Gunasekaran, Muthukumar ;
Sharma, Monal ;
Hachem, Ramsey ;
Bremner, Ross ;
Smith, Michael A. ;
Mohanakumar, Thalachallour .
JOURNAL OF IMMUNOLOGY, 2018, 200 (08) :2535-2541